Govt Job: For Deputy Director in Regional Drugs Testing Laboratory, CDSCO

The Regional Drugs Testing Laboratory (RDTL) in Guwahati is one of the five national laboratories of the Govt. of India for quality control of drugs and cosmetics and is established under the Indian Drugs & Cosmetics Act 1940, functioning under the administrative control of the Drugs Controller General of India and subordinate office under the Directorate General of Health Services, Ministry of Health & Family Welfare.

The laboratory was set up in the year 2002 for the entire North Eastern State including Sikkim and is housed in its own building at Guwahati.

Post: Deputy Director

Applications are invited from eligible candidates for appointment to the post of Deputy Director, Group ‘A’ Gazetted, Non-Ministerial, Pay Level-11 of the 7th CPC (Pre-revised scale of PB-3) (Rs.67,700/-2,08,700/-with Grade Pay of Rs.6600) in the Regional Drugs Testing Laboratory, Guwahati, Central Drugs Standard Control Organisation, Directorate General of Health Services, Ministry of Health & Family Welfare on absorption basis (including short-term contract).

Pay as per 7th CPC: Pay Level-11 of 7th CPC (Pre-revised scale of PB-3) (Rs.67,700/-2,000,08,700/-with Grade Pay of Rs.6600)

No. of Post: 1

Eligibility Criteria
Officers under the Central Government / State Government/Union Territories/Public undertaking / Universities / Autonomous or Statutory Organisation / Recognised Research Institutions / Semi- Govt.:

(i) holding analogous posts on regular basis; or

(ii) with 5 years regular service in Level-10 (PB-3, (Rs.56,100 – 1,77,500/-) with Grade Pay of Rs.5400) or equivalent; and possessing the educational qualifications and experience as laid down for direct recruits under Column 8 given below.

Note-Period of deputation/Contract including a period of deputation/contract in another ex-cadre post held immediately preceding this appointment in the same or some other organization/department of Central Government shall ordinarily not exceed 3 years.

The maximum age limit for appointment by deputation/absorption (including short-term contract) shall not be exceeding 56 years as of the closing date of the receipt of the applications).

Note-Only officers belonging to Central/State Government/Union Territory are eligible to be absorbed for appointment on absorption.

Educational qualifications and experience :
Essential
i) Master’s Degree in Chemistry or Pharmacy or Pharmaceutical Chemistry or Biochemistry or Pharmacology or Microbiology from a recognized university or equivalent

ii) 5 years experience in research and analysis of drugs/directing research/setting up and running of a laboratory and coordinating the activities of its different branches including two years of administrative experience.

Note 1: Qualifications are relaxable at the discretion of the Union Public Service Commission in case of candidates otherwise well qualified.

Note 2: The qualification(s) regarding experience is/are relaxable at the discretion of the Union Public Service Commission in the case of candidates belonging to Scheduled Castes or the Scheduled Tribes if, at any stage of selection, the Commission is of the opinion that sufficient number of candidates from these communities possessing the requisite experience are not likely to be available to fill up the posts received from them

Desirable: Doctorate degree in the relevant subject from a recognized university/institution

The list of documents to be sent along with the application

1. Application in prescribed format – Annexure-II duly filled in and signed by the candidate and countersigned with seal by the Cadre/Appointing
authority.

2. Attested copies of APAR/ACRs for the last 5 (five) years duly attested on each page by an officer, not below the rank of Under Secretary to the Government of India.

3. Integrity Certificate

4. Vigilance Clearance Certificate

5. Statement of major or minor penalties, if any, imposed on the officer during the last 10 years of service.

6. A certificate to the effect that the particulars furnished by the candidate have been verified and found correct as per service records.

7. Cadre Clearance Certificate.

Note: Incomplete applications or applications not accompanied by the above documents will be summarily rejected.

Cadre authorities/Heads of Department are requested to forward applications of eligible and willing candidates, whose services can be spared for appointment to the said post on a deputation/absorption basis (including short-term-contract), so as to reach Shri Amit Kumar, Deputy Director (Admn), Central Drugs Standard Control Organisation HQ, FDA Bhawan, Kotla Road, New Delhi-110002 within 60 days from the date of publication of this advertisement in the Employment News.

Related Posts

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

Pak-made illegal cosmetics recovered from Itwari shop

Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert